KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $293.0 million.

  • Elevance Health's Capital Expenditures fell 900.62% to $293.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 1114.65%. This contributed to the annual value of $1.1 billion for FY2025, which is 1114.65% down from last year.
  • As of Q4 2025, Elevance Health's Capital Expenditures stood at $293.0 million, which was down 900.62% from $360.0 million recorded in Q3 2025.
  • Over the past 5 years, Elevance Health's Capital Expenditures peaked at $360.0 million during Q3 2025, and registered a low of $196.0 million during Q1 2025.
  • For the 5-year period, Elevance Health's Capital Expenditures averaged around $295.3 million, with its median value being $299.5 million (2022).
  • As far as peak fluctuations go, Elevance Health's Capital Expenditures soared by 2450.98% in 2022, and later tumbled by 2974.91% in 2025.
  • Over the past 5 years, Elevance Health's Capital Expenditures (Quarter) stood at $340.0 million in 2021, then decreased by 12.35% to $298.0 million in 2022, then increased by 9.4% to $326.0 million in 2023, then fell by 1.23% to $322.0 million in 2024, then fell by 9.01% to $293.0 million in 2025.
  • Its last three reported values are $293.0 million in Q4 2025, $360.0 million for Q3 2025, and $267.0 million during Q2 2025.